Furthermore, suppression of the key intermediates in glutathione synthesis pathway may help explain why high SHLP2 levels are associated with lower risk of prostate cancer, as oxidative stress is involved in all aspects of tumor development (Xiao et al. 2017). The gene discussed is MT-RNR2; the disease is prostate cancer.